Jonathan Zung Ph.D. — Group President of Clinical Development & Commercialization Services for Covance Drug Development at Laboratory Corporation of America Holdings

Dr. Jonathan Zung, Ph.D., has been Group President of Clinical Development & Commercialization Services for Covance Drug Development at Laboratory Corporation of America Holdings since April 05, 2016. Dr. Zung leads a global organization with employees in 60 countries spanning all phases of clinical development and global market access services. He has more than 20 years of pharmaceutical development experience and has led and overseen large-scale development projects in oncology, immunology, cardiovascular disease and other major therapeutic areas. Before joining UCB, he served as Vice President and Head of Global Development Operations at Bristol-Myers Squibb, where he led a 1,400-person organization that managed clinical trials from Phase II through registration. He also held several positions of increasing responsibility at Pfizer Global Research and Development. He serves as Director of Clinical Data Interchange Standards Consortium, Inc. He served as a Member of The Florida Institute of Technology Board of Trustees from 2010 to 2016. Dr. Zung received his Doctorate in analytical chemistry from Emory University in Atlanta and has a bachelor's degree in chemistry from the Florida Institute of Technology in Melbourne, Florida.